MCM
PMVP icon

MAI Capital Management’s PMV Pharmaceuticals PMVP Stock Holding History

MAI Capital Management’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$178K Buy
+133,122
New +$171K ﹤0.01% 1833

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

MAI Capital Management's PMVP Position: Q2 2026 in Review

MAI Capital Management opened a new position in PMV Pharmaceuticals (PMVP) in Q2 2026: 133,122 shares worth $178K. The stake represents ﹤0.01% of the portfolio and ranks #1833 among its holdings.

64 funds tracked by Wall St. Rank hold PMVP as of Q2 2026.

  • MAI Capital Management held 133,122 shares of PMV Pharmaceuticals worth $178K as of Q2 2026.
  • PMV Pharmaceuticals was a new MAI Capital Management position in Q2 2026.
  • PMV Pharmaceuticals made up ﹤0.01% of MAI Capital Management's portfolio in Q2 2026, its #1833 holding.
  • 64 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.